Bausch Health’s DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
- Wednesday, December 30, 2020, 7:12
- PR Newswire
- Add a comment
LAVAL, QC, Dec. 30, 2020 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), today announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has granted an additional new indication for DEXAVEN…
About the Author
admin has written 20650 stories on this site.